Truist Securities Maintains Hold on Amgen, Raises Price Target to $398
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice TargetHot
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $380 to $398.
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $380 to $398.